K2M receives FDA 510(k) clearance for EVEREST Degenerative Spinal System

K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced at the International Society for the Advancement of Spine Surgery (SAS) Conference that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the EVEREST Degenerative Spinal System, a versatile top-loading polyaxial pedicle screw system featuring the ability to accommodate multiple levels of fixation rigidity to help surgeons individualize patient care. The system provides for both titanium and cobalt chrome rods of two different diameters, 5.5 and 6.0 mm, limiting inventory and increasing adaptability.

“EVEREST is a next generation system inspired by the lessons learned from our expanding product portfolio and has been designed to be a best-in-class degenerative fixation system.”

EVEREST is designed to maximize both osteoporotic and dense bone fixation and the modified square thread of the locking set screw may reduce the potential for cross-threading. Additionally, the mixed material screw head minimizes splay compared to a screw head made entirely of titanium, which improves the biomechanical performance of the construct.

"A combined team of surgeons and engineers worked closely together to design the EVEREST Degenerative Spinal System, which utilizes both titanium and cobalt chrome and optimizes thread pitch for use in both osteoporotic and dense bone fixation," stated Dr. John Carbone, Orthopedic Surgeon at Harborview Reconstructive Spine & Orthopedic Specialists. "In my opinion, the strength, range of motion, and stiffness of EVEREST provide surgeons the intraoperative flexibility to address a variety of surgical pathologies."

"FDA clearance for EVEREST is an important expansion of our product offering for treating Degenerative Disc Disease (DDD), as well as more complex pathologies," stated Eric Major, K2M's President and CEO. "EVEREST is a next generation system inspired by the lessons learned from our expanding product portfolio and has been designed to be a best-in-class degenerative fixation system."

Source:

K2M, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blue light exposure may accelerate bone growth and early puberty in rats